| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.0026 | 1 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |